{"title":"化学计量辅助紫外分光光度法定量头孢克洛混悬剂型","authors":"Kirtimaya Mishra, Budumuru Padmasri, Swetha Vegesna, Asra Jabeen, Abhilash Dash, Satyam Kumar, Diptimayee Jena","doi":"10.25258/ijpqa.14.3.46","DOIUrl":null,"url":null,"abstract":"In this current study, the quality by design (QbD) concept is used for creating and validating a unique, resilient, accurate, and reliable spectrophotometric approach to quantify cefaclor (CEF) in injections. Fractional factorial design (FFD) was a design implemented to screen the initial parameters. Moreover, the variables went through the central composite design (CCD) to assess the dependency and optimize the design. Several measures were analyzed statistically to determine the appropriateness of the data obtained from the experiments. At 265 nm, by the use of ethanol, cefaclor displays an absorption maximum. Variables like screening, slit-width, and sampling interval were recognized as critical methods and again, evaluation was done by a CCD. A good linearity was produced for cefaclor in the range of 2 to 12 μg/mL, with R2>0.9993. The process was determined for being perfect, having a good average percent recovery (greater than 100%). According to ICH guidelines, validation of the developed method was performed. By implementing QbD principles, the spectrophotometric was created and designed to integrate the quality into the method. The process was manifested for being flexible and appropriate for identifying CEF in pharmaceuticals.","PeriodicalId":14260,"journal":{"name":"International Journal of Pharmaceutical Quality Assurance","volume":"32 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Chemometric Assisted UV-Spectrophotometric Quantification of Cefaclor in Suspension Dosage Form\",\"authors\":\"Kirtimaya Mishra, Budumuru Padmasri, Swetha Vegesna, Asra Jabeen, Abhilash Dash, Satyam Kumar, Diptimayee Jena\",\"doi\":\"10.25258/ijpqa.14.3.46\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In this current study, the quality by design (QbD) concept is used for creating and validating a unique, resilient, accurate, and reliable spectrophotometric approach to quantify cefaclor (CEF) in injections. Fractional factorial design (FFD) was a design implemented to screen the initial parameters. Moreover, the variables went through the central composite design (CCD) to assess the dependency and optimize the design. Several measures were analyzed statistically to determine the appropriateness of the data obtained from the experiments. At 265 nm, by the use of ethanol, cefaclor displays an absorption maximum. Variables like screening, slit-width, and sampling interval were recognized as critical methods and again, evaluation was done by a CCD. A good linearity was produced for cefaclor in the range of 2 to 12 μg/mL, with R2>0.9993. The process was determined for being perfect, having a good average percent recovery (greater than 100%). According to ICH guidelines, validation of the developed method was performed. By implementing QbD principles, the spectrophotometric was created and designed to integrate the quality into the method. The process was manifested for being flexible and appropriate for identifying CEF in pharmaceuticals.\",\"PeriodicalId\":14260,\"journal\":{\"name\":\"International Journal of Pharmaceutical Quality Assurance\",\"volume\":\"32 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-09-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Pharmaceutical Quality Assurance\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.25258/ijpqa.14.3.46\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Pharmaceutical Quality Assurance","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25258/ijpqa.14.3.46","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
Chemometric Assisted UV-Spectrophotometric Quantification of Cefaclor in Suspension Dosage Form
In this current study, the quality by design (QbD) concept is used for creating and validating a unique, resilient, accurate, and reliable spectrophotometric approach to quantify cefaclor (CEF) in injections. Fractional factorial design (FFD) was a design implemented to screen the initial parameters. Moreover, the variables went through the central composite design (CCD) to assess the dependency and optimize the design. Several measures were analyzed statistically to determine the appropriateness of the data obtained from the experiments. At 265 nm, by the use of ethanol, cefaclor displays an absorption maximum. Variables like screening, slit-width, and sampling interval were recognized as critical methods and again, evaluation was done by a CCD. A good linearity was produced for cefaclor in the range of 2 to 12 μg/mL, with R2>0.9993. The process was determined for being perfect, having a good average percent recovery (greater than 100%). According to ICH guidelines, validation of the developed method was performed. By implementing QbD principles, the spectrophotometric was created and designed to integrate the quality into the method. The process was manifested for being flexible and appropriate for identifying CEF in pharmaceuticals.
期刊介绍:
INTERNATIONAL JOURNAL OF PHARMACEUTICAL QUALITY ASSURANCE is a quarterly international journal publishing the finest peer-reviewed research in the field of Pharmaceutical Quality Assurance and Pharmaceutical Analysis on the basis of its originality, importance, disciplinary interest, timeliness, accessibility, elegance, and surprising conclusions. IJPQA also provides rapid, authoritative, insightful and arresting news and interpretation of topical and coming trends affecting science, scientists and the wider public.